To view the PDF file, sign up for a MySharenet subscription.

JSE LIMITED - Dealings in securities by Directors, the Company Secretary and the JSE LTIS 2018 Trust

Release Date: 08/03/2019 17:24
Code(s): JSE     PDF:  
Wrap Text
Dealings in securities by Directors, the Company Secretary and the JSE LTIS 2018 Trust

JSE Limited
(Incorporated in the Republic of South Africa)
(Registration number: 2005/022939/06)
ISIN: ZAE000079711
Share Code: JSE
("JSE" or "the Company")


The JSE LTIS 2018 Trust ("Trust") has acquired 359 595 JSE ordinary
shares in the open market on behalf of executive directors, members of
the executive committee, the Company Secretary and senior members of
staff ("LTIS 2018 participants") to fulfil share awards granted to these
staff under the JSE’s Long-Term Incentive Scheme ("LTIS 2018").

These ordinary shares are held in trust and are restricted until all
vesting criteria are fulfilled whereupon the shares vest. To the extent
that the vesting criteria are not fulfilled the share awards are

The vesting of these restricted JSE ordinary shares is subject to –

(i)  the JSE achieving specified corporate performance targets over the
     measurement period; and
(ii) a LTIS 2018 participant remaining in the employ of the JSE for the
     vesting term (collectively "the vesting criteria").

These JSE ordinary shares were acquired on-market, with prior clearance,
at a volume-weighted average price of R159.80 per ordinary share. The
total transaction value amounted to R57 464 539. The daily high, low and
volume-weighted average for the various transactions were –

Dates in 2019
  that JSE       Number of JSE                 Daily high    Daily low
  ordinary         ordinary     Daily VWAP     price paid    price paid
   shares           shares      (cents per     (cents per    (cents per
  acquired         acquired       share)         share)        share)
  5 March          108 973        15948          16000        15902

  6 March          250 622        15994          16000        15930

The requisite approvals have been granted by shareholders at the
Company’s annual general meeting, in respect of the acquisition of JSE
ordinary shares in the open market and in respect of specific financial
assistance to the Trust for the purpose of acquiring these shares.


Following the acquisition of the JSE ordinary shares by the Trust as
disclosed above, the executive directors, members of the executive
committee and the Company Secretary, have on 7 March 2019 accepted grants
of restricted ordinary shares in the Company, as reflected in this

                                      Total number
                                      of restricted  Total Rand value
                                      JSE ordinary   of restricted JSE
                                         shares      ordinary shares      
                                      awarded and      awarded and       Nature of
    Executive           Role           accepted         accepted         interest
                   CEO & Executive                                       Direct
  NF Newton-King   Director             52 112          8 327 498        beneficial
                   CFO & Executive                                       Direct
  A Takoordeen     Director             16 710          2 670 258        beneficial  
                   Alternate                                             Direct
  JH Burke         Director             18 420          2 943 516        beneficial
                   Prescribed                                            Direct
  A Greenwood      Officer              17 776          2 840 605        beneficial
                   Prescribed                                            Direct
  D Khumalo        Officer              13 190          2 107 762        beneficial
                   Prescribed                                            Direct
  H Kotze          Officer              15 400          2 460 920        beneficial
                   Prescribed                                            Direct
  Z Morrison       Officer               9 626          1 538 235        beneficial       
                   Prescribed                                            Direct
  DM Nemer         Officer              20 372          3 255 446        beneficial
                   Prescribed                                            Direct
  M Randall        Officer              13 920          2 224 416        beneficial
                   Group Company                                         Direct
  GA Brookes       Secretary             7 854          1 255 069        beneficial

The restricted shares will vest in two tranches, one-half on 1 March 2022
and the remaining half on 1 March 2023, subject to the vesting criteria
as set out above being met.

The individual allocations (grant and acceptance) were approved by the
JSE’s Group Human Resources Committee and clearance to deal was granted
by the Chairman of the Board.

8 March 2019

RAND MERCHANT BANK (A division of FirstRand Bank Limited)

Date: 08/03/2019 05:24:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.

Email this JSE Sens Item to a Friend.

Share This Story